April 14, 2014

BV 4 Portfolio Company Celladon Receives Breakthrough Therapy Designation from FDA

MYDICAR is First Gene Therapy Reported to Receive Breakthrough Designation from FDA’s Center for Biologics Evaluation and Research (CBER)